A data mining approach for the elucidation of the action of putative etiological agents: Application to the non-genotoxic carcinogenicity of genistein

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 526, Issue 1-2, 2003, Pages 85-92

  Rosenkranz, Herbert S ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Carcinogenicity; Genistein; Virtual similarity index

Indexed keywords

AMPHOTERICIN B; AMPICILLIN; ASPARTAME; ATENOLOL; CAPSAICIN; CEFALORIDINE; CHLORPHENOTANE; CHOLESTEROL; COLCHICINE; CYTOCHALASIN B; DIAMORPHINE; DIETHYLSTILBESTROL; ESTRADIOL; GENISTEIN; KANAMYCIN; METOPROLOL; NADOLOL; PENICILLIN G; PETHIDINE; PHALLOIDIN; PHENYLALANINE; PYRETHRIN; ROFECOXIB; SIMVASTATIN; STREPTOMYCIN; SUCROSE; VERATRIDINE; VINBLASTINE;

ANIMAL CELL; ARTICLE; BIODEGRADABILITY; CARCINOGENICITY; CHEMICAL STRUCTURE; CHROMOSOME ABERRATION; COMPARATIVE TOXICOLOGY; CONTROLLED STUDY; CYTOTOXICITY; DNA REPAIR; DNA SYNTHESIS; DRUG ACTIVITY; DRUG MECHANISM; ESTROGEN ACTIVITY; GASTROINTESTINAL TOXICITY; GENETIC TOXICOLOGY; HUMAN; HUMAN CELL; HYPERSENSITIVITY; IMMUNOTOXICITY; LIVER TOXICITY; LYMPHOMA; MAXIMUM TOLERATED DOSE; MOUSE; MUTAGENICITY; NEUROTOXICITY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REPRODUCTIVE TOXICITY; SKIN PERMEABILITY; STRUCTURE ACTIVITY RELATION; TECHNIQUE; TOXICOLOGICAL PARAMETERS; TOXICOLOGY; VALIDATION PROCESS;

EID: 0037447975     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(03)00050-2     Document Type: Article

References (46)

1. Rosenkranz H.S., Cunningham A.R., Zhang Y.P., Claycamp H.G., Macina O.T., Sussman N.B., Grant S.G., Klopman G. Development, characterization and application of predictive-toxicology models. SAR QSAR Environ. Res. 10:1999;277-298.
2. Klopman G., Rosenkranz H.S. Prediction of carcinogenicity/mutagenicity using MULTICASE. Mutat. Res. 305:1994;33-46.
3. Klopman G., Rosenkranz H.S. Toxicity estimation by chemical substructure analysis: the Tox II program. Toxicol. Lett. 79:1995;145-155.
4. Zhang Y.P., Sussman N., Klopman G., Rosenkranz H.S. Development of methods to ascertain the predictivity and consistency of SAR models: application to the US National Toxicology Program rodent carcinogenicity bioassays. Quant. Struct. Activ. Relat. 16:1997;290-295.
5. Pollack N., Cunningham A.R., Klopman G., Rosenkranz H.S. Chemical diversity approach for evaluating mechanistic relatedness among toxicological phenomena. SAR QSAR Environ. Res. 10:1999;533-543.
6. H.S. Rosenkranz, Structural concepts in the prediction of the toxicity of therapeutical agents, in: Burger's Medicinal Chemistry and Drug Discovery, Wiley, New York, NY, 2002, in press.
7. Ashby J. Mouse uterine carcinogenicity of genistein: the currently most secure example of non-genotoxic rodent carcinogenicity? Mutat. Res. 483:2001;107-108.
8. Marselos M., Tomatis L. Diethylstilbestrol. I. Pharmacology, toxicology and carcinogenicity in humans. Eur. J. Cancer. 28A:1992;1182-1189.
9. Peterson G. Evaluation of the biochemical targets of genistein in tumor cells. J. Nutr. 125:1995;784S-789S.
10. Lamartiniere C.A., Moore J.B., Brown N.M., Thompson R., Hardin M.J., Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis. 16:1995;2833-2840.
11. Fotsis T., Pepper M., Adlercreutz H., Fleischmann G., Hase T., Montesano R., Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2690-2694.
12. Mutoh M., Takahashi M., Fukuda K., Komatsu H., Enya T., Matsushima-Hibiya Y., Mutoh H., Sugimura T., Wakabayashi K. Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship. Jpn. J. Cancer Res. 91:2000;686-691.
13. Roy D., Liehr L. Metabolic oxidation of diethylstilbestrol to diesthylstilbestrol-4′,4″-quinone in Syrian hamsters. Carcinogenesis. 10:1989;1241-1245.
14. Rosenkranz H.S., Klopman G. The structural basis of the mutagenicity of chemicals in Salmonella typhimurium: The National Toxicology Program database. Mutat. Res. 228:1990;51-80.
15. Liu M., Sussman N., Klopman G., Rosenkranz H.S. Estimation of the optimal database size for structure-activity analyses: the Salmonella mutagenicity database. Mutat. Res. 358:1996;63-72.
16. Zeiger E., Ashby J., Bakale G., Enslein K., Klopman G., Rosenkranz H.S. Prediction of Salmonella mutagenicity. Mutagenesis. 11:1996;471-484.
17. Mersch-Sundermann V., Schneider U., Klopman G., Rosenkranz H.S. SOS-induction in E. coli and Salmonella mutagenicity: a comparison using 330 compounds. Mutagenesis. 9:1994;205-224.
18. Mersch-Sundermann V., Klopman G., Rosenkranz H.S. Chemical structure and genotoxicity: studies of the SOS chromotest. Mutat. Res. 340:1996;81-91.
19. Rosenkranz H.S., Klopman G. Structural basis of carcinogenicity in rodents of genotoxicants and non-genotoxicants. Mutat. Res. 228:1990;105-124.
20. Cunningham A.R., Rosenkranz H.S., Zhang Y.P., Klopman G. Identification of "genotoxic" and "non-genotoxic" alerts for cancer in mice: the carcinogenic potency database. Mutat. Res. 398:1998;1-17.
21. Cunningham A.R., Rosenkranz H.S., Klopman G. Identification of structural features and associated mechanisms of action for carcinogens in rats. Mutat. Res. 405:1998;9-28.
22. Zhang Y.P., Sussman N., Macina O.T., Rosenkranz H.S., Klopman G. Prediction of the carcinogenicity of a second group of chemicals undergoing carcinogenicity testing. Environ. Health Perspect. 104:1996;1045-1050.
23. O.T. Macina, Y.P. Zhang, H.S. Rosenkranz, Improved predictivity of carcinogens: the use of a battery of SAR models, in: K.T. Kitchen (Ed.), Testing, Predicting and Interpreting Carcinogenicity, Marcel Dekker, New York, NY, 1998, pp. 227-250.
24. Rosenkranz M., Rosenkranz H.S., Klopman G. Intercellular communication, tumor promotion and non-genotoxic carcinogenesis: relationships based upon structural considerations. Mutat. Res. 381:1997;171-188.
25. Rannug U., Sjogren M., Rannug A., Gillner M., Toftgard R., Gustafsson J.A., Rosenkranz H., Klopman G. Use of artificial intelligence in structure-affinity correlations of 2,3,7,8-tetrachlorodibenzo-P-dioxin (TCDD) receptor ligands. Carcinogenesis. 12:1991;2007-2016.
26. Grant S.G., Zhang Y.P., Klopman G., Rosenkranz H.S. Modeling the mouse lymphoma forward mutational assay: the Gene-Tox Program database. Mutat. Res. 465:2000;201-229.
27. Rosenkranz H.S., Ennever F.K., Dimayuga M., Klopman G. Significant differences in the structural basis of the induction of sister chromatid exchanges and chromosomal aberrations in Chinese hamster ovary cells. Environ. Mol. Mutagen. 16:1990;149-177.
28. Zhang Y.P., Praagh A.V., Klopman G., Rosenkranz H.S. Structural basis of the induction of unscheduled DNA synthesis in rat hepatocytes. Mutagenesis. 9:1994;141-149.
29. Yang W.-L., Klopman G., Rosenkranz H.S. Structural basis of the in vivo induction of micronuclei. Mutat. Res. 272:1992;111-124.
30. Labbauf A., Klopman G., Rosenkranz H.S. Dichotomous relationship between DNA reactivity and the induction of sister chromatid exchanges in vivo and in vitro. Mutat. Res. 377:1997;37-52.
31. Macina O.T., Klopman G., Rosenkranz H.S. Structural basis of sensory irritation. Inhalation Toxicol. 9:1997;465-476.
32. Rosenkranz H.S., Zhang Y.P., Klopman G. The development and characterization of an SAR model of the Draize eye irritation test. ATLA. 20:1998;779-809.
33. Karol M.H., Graham C., Gealy R., Macina O.T., Sussman N., Rosenkranz H. Structure-activity relationships and computer-assisted analysis of respiratory sensitization potential. Toxicol. Lett. 86:1996;187-191.
34. Graham C., Rosenkranz H., Karol M.H. Structure-activity model of chemicals that cause human respiratory sensitization. Reg. Toxicol. Pharmacol. 26:1997;296-306.
35. Graham C., Gealy R., Macina O.T., Karol M.H., Rosenkranz H.S. QSAR for allergic contact dermatitis. Quant. Struct. Activ. Relat. 15:1996;224-229.
36. NIOSH, Registry of Toxic Effects of Chemical Substances (RTECS): http://www.cdc.gov/niosh/rtecs.html (2001).
37. Rosenkranz H.S., Klopman G. Structural relationships between mutagenicity, maximum tolerated dose, and carcinogenicity in rodents. Environ. Mol. Mutagen. 21:1993;193-206.
38. Matthews E.J., Spalding J.W., Tennant R.W. Transformation of BALB/C-3T3 cells. V. Transformation responses of 166 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassay. Environ. Health Perspect. 101:1993;347-482.
39. Zhu X., Rosenkranz H.S. Structural basis of the toxicity of chemicals in cultured human HeLa cells. ATLA. 28:2000;557-574.
40. Swenberg J.A., Short B., Borghoff S., Strasser J., Charbonneau M. The comparative pathobiology of α2u-globulin nephropathy. Toxicol. Appl. Pharmacol. 97:1989;35-46.
41. Strobl G.R., von Kruedener S., Stockigt J., Guengerich F.P., Wolff T. Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. J. Med. Chem. 36:1993;1136-1145.
42. Gomez J., Macina O.T., Mattison D.R., Zhang Y.P., Klopman G., Rosenkranz H.R. Structural determinants of developmental toxicity in hamsters. Teratology. 60:1999;190-205.
43. Ghanooni M., Mattison Y.P., Zhang Y.P., Macina O.T., Rosenkranz H.S., Klopman G. Structural determinants associated with risk of human developmental toxicity. Am. J. Obstet. Gynecol. 76:1997;799-806.
44. Nendza M., Russom C.L. QSAR modelling of the ERL-D fathead minnow acute toxicity database. Xenobiotica. 21:1991;147-170.
45. H.S. Rosenkranz, Y.P. Zhang, G. Klopman, Perspective on the use of structure-activity expert systems in toxicology, in: C.L. Galli, A.M. Goldberg, M. Marinovich (Eds.), Modulation of Cellular Responses in Toxicity, NATO Cell Biology Series, 1995, pp. 37-89.
46. Kirchner L.A., Moody R.P., Doyle E., Bose R., Jeffery J., Chu I. The prediction of skin permeability by using physicochemical data. ATLA. 25:1997;359-370.